QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (98) Citing Articles via Google Scholar Google Scholar Articles by Richardson, J. D. Articles by Hargreaves, K. M. Search for Related Content PubMed PubMed Citation Articles by Richardson, J. D. Articles by Hargreaves, K. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOHEXANOL TRITIUM

 Previous Article  |  Next Article 

The Journal of Neuroscience, January 1, 1998, 18(1):451-457

Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia

Jennelle Durnett Richardson¹, Lin Aanonsen³, and Kenneth M. Hargreaves^{1, 2}

Departments of ¹ Pharmacology and ² Restorative Sciences, University of Minnesota, Minneapolis, Minnesota 55455, and ³ Department of Biology, Macalester College, St. Paul, Minnesota 55105

Cannabinoids, such as ⁹-THC, are capable of inhibiting nociception, i.e., pain transmission, at least in part, by interacting with spinal G_i/G_o-coupled cannabinoid receptors. What is not known, however, is the antinociceptive role of endogenous spinal cannabinoids. If endogenous cannabinoids modulate basal nociceptive thresholds, then alterations in this system could be involved in the etiology of certain pain states. In this report we provide evidence for tonic modulation of basal thermal nociceptive thresholds by the spinal cannabinoid system. Administration of oligonucleotides directed against CB₁ cannabinoid receptor mRNA significantly reduced spinal cannabinoid binding sites and produced significant hyperalgesia when compared with a randomer oligonucleotide control. A second method used to reduce activity of the spinal cannabinoid receptor was intrathecal administration of the cannabinoid receptor antagonist SR 141716A. SR 141716A evoked thermal hyperalgesia with an ED₅₀ of 0.0012 fmol. The SR 141716A-induced hyperalgesia was dose-dependently blocked by the administration of D-AP-5 or MK-801, two antagonists to the NMDA receptor. These results indicate that there is tonic activation of the spinal cannabinoid system under normal conditions. Furthermore, hypoactivity of the spinal cannabinoid system results in an NMDA-dependent hyperalgesia and thus may participate in the etiology of certain chronic pain states.

Key words: endogenous cannabinoid; SR 141716A; glutamate; NMDA; hyperalgesia; nociceptive threshold; tonic; spinal cord

---

Copyright © 1998 Society for Neuroscience  0270-6474/98/181451-07$05.00/0

This article has been cited by other articles:

				M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe Endocannabinoid-Mediated Control of Synaptic Transmission Physiol Rev, January 1, 2009; 89(1): 309 - 380. [Abstract] [Full Text] [PDF]

				M. D. Jhaveri, D. Richardson, D. A. Kendall, D. A. Barrett, and V. Chapman Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition in a Rat Model of Neuropathic Pain J. Neurosci., December 20, 2006; 26(51): 13318 - 13327. [Abstract] [Full Text] [PDF]

				C. Liu and J. M. Walker Effects of a Cannabinoid Agonist on Spinal Nociceptive Neurons in a Rodent Model of Neuropathic Pain J Neurophysiol, December 1, 2006; 96(6): 2984 - 2994. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]

				M. J. Khodayar, B. Shafaghi, N. Naderi, and M.-R. Zarrindast Antinociceptive effect of spinally administered cannabinergic and 2-adrenoceptor drugs on the formalin test in rat: possible interactions J Psychopharmacol, January 1, 2006; 20(1): 67 - 74. [Abstract] [PDF]

				S. M. Rawls, A. Cowan, R. J. Tallarida, E. B. Geller, and M. W. Adler N-Methyl-D-aspartate Antagonists and WIN 55212-2 [4,5-Dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a Cannabinoid Agonist, Interact to Produce Synergistic Hypothermia J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 395 - 402. [Abstract] [Full Text] [PDF]

				S. A. Varvel and A. H. Lichtman Evaluation of CB1 Receptor Knockout Mice in the Morris Water Maze J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 915 - 924. [Abstract] [Full Text] [PDF]

				V. Morisset and L. Urban Cannabinoid-Induced Presynaptic Inhibition of Glutamatergic EPSCs in Substantia Gelatinosa Neurons of the Rat Spinal Cord J Neurophysiol, July 1, 2001; 86(1): 40 - 48. [Abstract] [Full Text] [PDF]

				D McCarthy Prostaglandins, COX-2, and sensory perception Gut, December 1, 2000; 47(90004): iv66 - 68. [Full Text] [PDF]

				B. R. Martin, I. Beletskaya, G. Patrick, R. Jefferson, R. Winckler, D. G. Deutsch, V. Di Marzo, O. Dasse, A. Mahadevan, and R. K. Razdan Cannabinoid Properties of Methylfluorophosphonate Analogs J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1209 - 1218. [Abstract] [Full Text]

				D. Melck, L. De Petrocellis, P. Orlando, T. Bisogno, C. Laezza, M. Bifulco, and V. Di Marzo Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation Endocrinology, January 1, 2000; 141(1): 118 - 126. [Abstract] [Full Text] [PDF]

				J. M. Walker, S. M. Huang, N. M. Strangman, K. Tsou, and M. C. Sanudo-Pena Pain modulation by release of the endogenous cannabinoid anandamide PNAS, October 12, 1999; 96(21): 12198 - 12203. [Abstract] [Full Text] [PDF]

				A. Zimmer, A. M. Zimmer, A. G. Hohmann, M. Herkenham, and T. I. Bonner Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice PNAS, May 11, 1999; 96(10): 5780 - 5785. [Abstract] [Full Text] [PDF]

				A. G. Hohmann, K. Tsou, and J. M. Walker Cannabinoid Suppression of Noxious Heat-Evoked Activity in Wide Dynamic Range Neurons in the Lumbar Dorsal Horn of the Rat J Neurophysiol, February 1, 1999; 81(2): 575 - 583. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help